Fritextsökning
Innehållstyper
-
Avtalet med Almirall sägs upp
Index får tillbaka de europeiska rättigheterna för läkemedelskandidaten Kappaproct mot ulcerös kolit.
-
A smart company takes care of its best
Lundbeck didn't have to look far to find it's new international Director of Marketing. The talent was already in the house.
-
Nano-antikropp från alpacka blockerade coronavirus
Ett fragment av en antikropp från en alpacka verkar kunna blockera det nya corona-viruset från att ta sig in i celler.
-
Nya resultat om immunförsvarets reaktion vid svår covid-19
Forskare har identifierat flera celltyper som är centrala vid immunförsvarets reaktion vid covid-19.
-
Laboratory food
VWR exhibits laboratory tools with molecular gastronomy Rotary evaporators and magnetic stirrers - for making food. VWR tries out new ways for the exhibition at...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Digitalisering och kliniska prövningar
Effektivare kliniska prövningar och ny teknologi för dokumentation av behandlingar - Digitaliseringen öppnar många möjligheter. Ola Björkman rapporterar från BIO i San Diego.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Sweden Bio skär ner
Branschorganisationen genomför en omorganisation för att hålla i kostnaderna. Den nya organisationen kommer nu att bli mer virtuell och fokusera på medlemsnytta.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Hallå där Peter Zerhouni…
… som tillträdde som vd på biotechföretaget Index Pharmaceuticals tisdagen 1 april. Vad tar du med dig från din förra tjänst, som vd på vaccinbolaget Diamyd?
-
KI mörkade kritik
- ledningen påverkade oberoende experters utvärdering.
-
Per Hammargren, Sales Director, ICU Scandinavia AB
Why are you going to Scanlab and Biotech Forum?
-
165 miljoner mot läkemedelsrester
Regeringen satsar 165 miljoner kronor under tre år för att minska utsläppen av läkemedelsrester i miljön.
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown....
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Ny design på klinstudie
I ett samarbete mellan FDA, NIH och läkemedelsindustrin utvärderas ett flertal behandlingar i samma studie.
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
Köper upp AI-teknik för embryon
Vitrolife i avtal med australiska bolag.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.